Oncogenic features of the JMJD2A histone demethylase in breast cancer.

作者: WILLIAM L. BERRY , SOOK SHIN , STAN A. LIGHTFOOT , RALF JANKNECHT

DOI: 10.3892/IJO.2012.1618

关键词: Adjuvant therapyBreast cancerDownregulation and upregulationCancer researchEstrogen receptorCyclin D1BiologyCell cycleDemethylaseOncogene

摘要: Estrogen receptor α (ERα) plays a pivotal role in the genesis of majority breast tumors. Consequently, endocrine therapy is now routinely utilized clinic for treatment ERα-positive cancer patients. However, how ERα activity becomes dysregulated cells remains to be elucidated. The aim this study was show that histone demethylase JMJD2A, also known as KDM4A, capable forming complex with in vivo. Moreover, wild-type but not catalytically impaired mutant, able strongly coactivate ERα-mediated transcription. Consistently, downregulation JMJD2A human T47D led decreased expression cyclin D1, prominent target gene and cell cycle regulator. induced reduction growth cells. In addition, we found overexpressed tumors both at mRNA protein level. Taken together, these data indicate overexpression may contribute tumor formation by stimulating breast-relevant oncoprotein. As such, small molecule drugs targeting catalytic center might useful adjuvant therapy.

参考文章(54)
Lucia Altucci, M Beato, F Bresciani, M Truss, Mg Parker, A. Weisz, L Cicatiello, S Dauvois, Sica, R Addeo, 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene. ,vol. 12, pp. 2315- 2324 ,(1996)
Missag H. Parseghian, Robert L. Newcomb, Sara T. Winokur, Barbara A. Hamkalo, The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts. Chromosome Research. ,vol. 8, pp. 405- 424 ,(2000) , 10.1023/A:1009262819961
G Liu, A Bollig-Fischer, B Kreike, M J van de Vijver, J Abrams, S P Ethier, Z -Q Yang, Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene. ,vol. 28, pp. 4491- 4500 ,(2009) , 10.1038/ONC.2009.297
Eric J. Wagner, Phillip B. Carpenter, Understanding the language of Lys36 methylation at histone H3 Nature Reviews Molecular Cell Biology. ,vol. 13, pp. 115- 126 ,(2012) , 10.1038/NRM3274
Jianmin Wu, Ralf Janknecht, Regulation of the ETS Transcription Factor ER81 by the 90-kDa Ribosomal S6 Kinase 1 and Protein Kinase A Journal of Biological Chemistry. ,vol. 277, pp. 42669- 42679 ,(2002) , 10.1074/JBC.M205501200
Sook Shin, Tae-Dong Kim, Fang Jin, Jan M. van Deursen, Scott M. Dehm, Donald J. Tindall, Joseph P. Grande, Jan-Marie Munz, George Vasmatzis, Ralf Janknecht, Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81 Cancer Research. ,vol. 69, pp. 8102- 8110 ,(2009) , 10.1158/0008-5472.CAN-09-0941
Luciano De Haro, Ralf Janknecht, Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter Genomics. ,vol. 85, pp. 493- 502 ,(2005) , 10.1016/J.YGENO.2004.12.003
Yongmin Liu, Chunhua Lu, Qiang Shen, Debbie Munoz-Medellin, Heetae Kim, Powel H Brown, AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity Oncogene. ,vol. 23, pp. 8238- 8246 ,(2004) , 10.1038/SJ.ONC.1207889
Julia Knebel, Luciano De Haro, Ralf Janknecht, Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71 Journal of Cellular Biochemistry. ,vol. 99, pp. 319- 329 ,(2006) , 10.1002/JCB.20945